Overview

Gender

male

Gerard is a co-founder and has served as our Chief Innovation Officer since 2014. Gerard has an extensive background in RNA modulation and orphan drug discovery and development and is currently in charge of our Innovation unit. Gerard has more than twenty-five years of senior managerial experience in growing biotech companies. Prior to joining our company, Gerard worked at Isa Pharmaceuticals B.V. as its Chief Executive Officer. Gerard co-founded Prosensa Holding N.V., growing it to become a well-known clinical stage RNA modulation company, and held various positions including Chief Executive Officer and Chief Development Officer. Gerard also worked at Pharming B.V.. He is a passionate and driven pioneer of early stage technologies. Gerard has a master’s degree in chemistry and molecular biology from Leiden University in 1987 and pursued PhD work at Leiden University.
Herman de Boer. Gerard led the company through several financing rounds, most recently a series B round. He is trained as a molecular biologist.